期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Subchronic Oral Toxicity Evaluation of Lanthanum: A 90-day, Repeated Dose Study in Rats 被引量:10
1
作者 FANG Hai Qin YU Zhou +5 位作者 ZHI Yuan FANG Jin LIChen Xi WANG Yi Mei PENG Shuang Qing JIA Xu Dongl 《Biomedical and Environmental Sciences》 SCIE CAS CSCD 2018年第5期363-375,共13页
Objective The present study was undertaken to evaluate the subchronic toxicity of lanthanum and to determine the no observed adverse effect level(NOAEL),which is a critical factor in the establishment of an acceptab... Objective The present study was undertaken to evaluate the subchronic toxicity of lanthanum and to determine the no observed adverse effect level(NOAEL),which is a critical factor in the establishment of an acceptable dietary intake(ADI).Methods In accordance with the Organization for Economic Co-operation and Development(OECD) testing guidelines,lanthanum nitrate was administered once daily by gavage to Sprague-Dawley(SD) rats at dose levels of 0,1.5,6.0,24.0,and 144.0 mg/kg body weight(BW) per day for 90 days,followed by a recovery period of 4 weeks in the 144.0 mg/kg BW per day and normal control groups.Outcome parameters were mortality,clinical symptoms,body and organ weights,serum chemistry,and food consumption,as well as ophthalmic,urinary,hematologic,and histopathologic indicators.The benchmark dose(BMD) approach was applied to estimate a point of departure for the hazard risk assessment of lanthanum.Results Significant decreases were found in the 144.0 mg/kg BW group in the growth index,including body weight,organ weights,and food consumption.This study suggests that the NOAEL of lanthanum nitrate is 24.0 mg/kg BW per day.Importantly,the 95% lower confidence value of the benchmark dose(BMDL) was estimated as 9.4 mg/kg BW per day in females and 19.3 mg/kg BW per day in males.Conclusion The present subchronic oral exposure toxicity study may provide scientific data for the risk assessment of lanthanum and other rare earth elements(REEs). 展开更多
关键词 LANTHANUM Subchronic toxicity 90-day repeated oral dose test No observed adverse effectlevel Acceptable dietary intake Benchmark dose
下载PDF
六苄基六氮杂异伍兹烷亚慢性经口毒性试验研究 被引量:1
2
作者 刘志永 高俊宏 +5 位作者 王鸿 岳红 高永超 卢青 孙成辉 宋建伟 《工业卫生与职业病》 CAS 2018年第4期255-259,共5页
目的进行大鼠亚慢性经口毒性试验,获得六苄基六氮杂异伍兹烷(HBIW)的最大无作用剂量水平。方法将80只成年SPF级SD大鼠按体质量随机分为4组,3个染毒组每天的染毒剂量分别为111、333和1 000 mg/kg HBIW,对照组给予相同体积淀粉溶液灌胃... 目的进行大鼠亚慢性经口毒性试验,获得六苄基六氮杂异伍兹烷(HBIW)的最大无作用剂量水平。方法将80只成年SPF级SD大鼠按体质量随机分为4组,3个染毒组每天的染毒剂量分别为111、333和1 000 mg/kg HBIW,对照组给予相同体积淀粉溶液灌胃,连续给药90 d。实验结束后经腹主动脉采血,分别进行血液生化、血常规和凝血指标分析。对所有动物行大体解剖,取其脏器进行称重,并进行病理组织学检查。结果与对照组相比,1 000 mg/kg染毒组雌、雄性大鼠血小板压积(PCT)[(1.37±0.21)%,(1.40±0.27)%]、PLT[(1 587.56±243.62)109/L,(1 694.40±308.87)109/L]以及雌性大鼠红细胞分布宽度变异系数(RDW-CV)(29.741.24)%明显升高(P〈0.05),1 000 mg/kg染毒组雄性大鼠大型血小板比率(P-LCR)(13 37±2 04)%、平均血红蛋白含量(MCH)(16.65±0.44)pg、平均血小板体积(MPV)(8.25±0.27)fl明显降低(P〈0.05);333和1 000 mg/kg染毒组雄性大鼠心[(0.34±0.04),(0.34±0.04)]与肝[(2.59±0.13),(2.85±0.37)]脏器系数明显升高(P〈0.05),333 mg/kg染毒组雄性大鼠以及111 mg/kg染毒组雌性大鼠肺脏器系数[(0.72±0.22),(0.69±0.10)]明显升高(P〈0.05);病理组织学检查结果显示,333和1 000 mg/kg染毒组雄性大鼠分别有2和3只出现肝细胞嗜酸性变,并伴有肝细胞轻度肿胀;333 mg/kg染毒组雄性大鼠肺脏出现炎细胞浸润,1 000 mg/kg染毒组出现肺泡上皮细胞肿胀。结论 HBIW可能造成大鼠免疫力降低和轻度贫血,其对大鼠毒性作用靶器官为肝脏和肺脏,最大无作用剂量为111 mg/kg。 展开更多
关键词 六苄基六氮杂异伍兹烷 亚慢性经口毒性试验 最大无作用剂量
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部